Client Questionnaire

This is the first step in our process of evaluating the technology you are developing. Please complete it to the best of your ability and a member of our team will reach out to you shortly.

Skipper has a minimum proof of concept (POC) requirement of in vivo efficacy in lung and/or pancreatic cancer models for therapeutics and training set data with retrospective human tissue samples for biomarker assays. For medical devices, we require preliminary data using a POC prototype.